Latest news
Ahead‑of‑Schedule DME Trial Enrollment Could Be A Game Changer For EyePoint (EYPT) - simplywall.stsimplywall.st · Wed, 05 Aug 2026 05:24:44 GMTAcurx's ~550-Patient Trial Could Support C. diff Treatment, Recurrence Reduction - Stock TitanStock Titan · Mon, 03 Aug 2026 12:00:00 GMTThe Genetics Are Global. Your Enrollment Plan Isn’t. - The Clinical Trial VanguardThe Clinical Trial Vanguard · Wed, 29 Jul 2026 06:51:08 GMT